- Daniel D. Adams, Protein Sciences Corporation
- Jack M. Anthony, Founder, BioMentorz
- Paul Bolno, President and CEO, WaVe Life Sciences
- Do Hyun Cho, PhD, President & CEO, W Medical Srategy Group
- Robert DeBenedetto, President & CEO, SFJ Pharmaceuticals, Inc.
- Yuan-Hua Ding, PhD, Senior Director & Head of External R&D Innovation – Asia/Pacific, Pfizer Worldwide Research & Development
- Iain D. Dukes, D. Phil., Senior Vice President, MRL Licensing & External Scientific Affairs, Merck
- Jamie Egan, Senior Vice President, Corporate Development, Anges-MG, Inc
- David P. Flores, Co-Founder, President & CEO, BioCentury Publications Inc.
- Les Funtleyder, Director of Strategic Investments, OPKO Health
- John M. Gill, Co-Founder and former President & CEO of Tetralogic Pharmaceuticals
- Glen Giovannetti, Global Biotechnology Leader, EY, LLP
- Kimberly Ha, Senior Director, FTI Consulting
- Chizuko Koseki, Founder & Director, transB Ltd
- Kiyoshi Kurokawa, Professor, National Graduate Institute for Policy Studies & Science Advisor, National Diet, Japan
- Anjiang (Vincent) Liu, Managing Director, International Investment & Chief Representative, NY Office, FosunPharma Group
- Keiko Oishi, Senior Managing Director, CMIC Co., Ltd.
- Grace L. Pan, Partner, Orrick, Herrington & Sutcliffe LLP
- Nathan (Nick) B. Pliam, MD, PhD, Scientist-in-Residence, Bay City Capital LLC
- Terence G. Porter, PhD, Vice President, Search & Evaluation, Global Business Development, Takeda Pharmaceuticals International, Inc.
- Goro Takeda, Venture Partner, Sofinnova Ventures
- Gunther Winkler, PhD, Founder and CEO, Biometheus LLC
- Alan Yan, Co-Founder, President & CEO, Beijing SynerCare Pharma Tech Co., Ltd.
- Christopher Yochim, former Head of External Relations, Global Product and Portfolio Strategy GPPS, AstraZeneca
- Wei Zhang, Ph.D., Head, Corporate Development, Good Start Genetics Inc.